MedTrace Logo

Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening

NCT00207636 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 812

Last updated 2025-01-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to develop and evaluate a computer-based decision aid (DA) for use by men considering prostate-specific antigen (PSA) screening for prostate cancer. Major medical organizations recommend that men discuss the risks and benefits of this test with their physician before making the decision. This educational, interactive DA will help them prepare for that discussion.

Conditions

Interventions

BEHAVIORAL

Computer Assisted Decision making tool

The intervention consisted of access to a computer tailored decision aid designed to promote informed decision making.

Sponsors & Collaborators

Principal Investigators

  • Jennifer D Allen, PN MPH ScD · Dana-Farber Cancer Institute; Harvard School of Public Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-12-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00207636 on ClinicalTrials.gov